It was a pleasure to catch up with our Editorial Board member, Prof. Sunil Shah (Birmingham and Midland Eye Centre, Birmingham, UK), who explained the impact of the Photon Ultraviolet C (UVC) device that he has developed.
Questions
- Could you give us an overview of the health burden of corneal infections in developing countries? (00:08)
- What is the mechanism of action of the Photon Ultraviolet C (UVC) device you have developed? (01:50)
- What will be the impact of this device on clinical practice? (03:20)
Speaker Disclosure: Prof. Sunil Shah has no financial or non-financial relationships or activities to declare in relation to this interview.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of EURETINA 2020.
